Analysts expect Columbia/HCA's stock to continue to face near-term pressure but said the company will remain a market leader over the long-term .NEW YORK 1997-03-31 While shares of Columbia/HCA Healthcare Corp took a beating Monday following a federal probe and media reports about its billing practices , industry analysts continued to support the stock .Link: [Comments: s1 explains which stock "the stock" in s2 is.]Columbia/HCA lost 4-3/4 to 33 and was the heavily traded issue on the New York Stock Exchange .Columbia/HCA said it was not given the opportunity to review the New York Times' data and could not address the newspaper's findings .Anyone who is selling will probably regret it long-term , _" said Brian Eisenbarth , an analyst with Collins & Co .The stock will rebound , but I expect continued negative commentary to pressure the stock for the near-term , _" John Hindelong , an analyst with Donaldson , Lufkin & Jenrette ."_ What would make me uncomfortable is if the government went into other markets and locations at Columbia .Chiarelli said he continues to rate the stock as a buy .The probe covered a "_ broad range of records and documents _" and was completed by March 20 , the company said .